Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
- DOI
- 10.1056/nejmoa2211644
- Published
- 2023 Feb 23
- Container
- The New England journal of medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2211644,
title = {Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.},
author = {Pipe SW and Leebeek FWG and Recht M and Key NS and Castaman G and Miesbach W and Lattimore S and Peerlinck K and Van der Valk P and Coppens M and Kampmann P and Meijer K and O'Connell N and Pasi KJ and Hart DP and Kazmi R and Astermark J and Hermans CRJR and Klamroth R and Lemons R and Visweshwar N and von Drygalski A and Young G and Crary SE and Escobar M and Gomez E and Kruse-Jarres R and Quon DV and Symington E and Wang M and Wheeler AP and Gut R and Liu YP and Dolmetsch RE and Cooper DL and Li Y and Goldstein B and Monahan PE},
year = {2023},
journal = {The New England journal of medicine},
doi = {10.1056/nejmoa2211644},
url = {https://doi.org/10.1056/nejmoa2211644}
}RIS
TY - JOUR TI - Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B. AU - Pipe SW AU - Leebeek FWG AU - Recht M AU - Key NS AU - Castaman G AU - Miesbach W AU - Lattimore S AU - Peerlinck K AU - Van der Valk P AU - Coppens M AU - Kampmann P AU - Meijer K AU - O'Connell N AU - Pasi KJ AU - Hart DP AU - Kazmi R AU - Astermark J AU - Hermans CRJR AU - Klamroth R AU - Lemons R AU - Visweshwar N AU - von Drygalski A AU - Young G AU - Crary SE AU - Escobar M AU - Gomez E AU - Kruse-Jarres R AU - Quon DV AU - Symington E AU - Wang M AU - Wheeler AP AU - Gut R AU - Liu YP AU - Dolmetsch RE AU - Cooper DL AU - Li Y AU - Goldstein B AU - Monahan PE PY - 2023 JO - The New England journal of medicine DO - 10.1056/nejmoa2211644 UR - https://doi.org/10.1056/nejmoa2211644 ER -
APA
SW, P., FWG, L., M, R., NS, K., G, C., W, M., S, L., K, P., P, V. D. V., M, C., P, K., K, M., N, O., KJ, P., DP, H., R, K., J, A., CRJR, H., R, K., R, L., N, V., A, V. D., G, Y., SE, C., M, E., E, G., R, K., DV, Q., E, S., M, W., AP, W., R, G., YP, L., RE, D., DL, C., Y, L., B, G., & PE, M. (2023). Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2211644
Source records
- pubmed · retrieved 2026-09-27T15:24:31.136Z